Mark A. McElwain

Complete Genomics (United States)

Papers

1

Total Citations

13

H-Index

1

About

Mark A. McElwain is a leading figure in genomics, whose work has fundamentally advanced the field of molecular haplotyping—the process of determining the specific combination of genetic variants inherited from each parent. His primary research focuses on developing cost-effective, high-throughput technologies for genome-wide analysis, with a particular emphasis on long-range genomic information. McElwain’s most notable contribution is the pioneering Long Fragment Read (LFR) technology, a revolutionary approach that enables high-quality, genome-wide molecular haplotyping at a fraction of the cost of traditional methods. This innovation, detailed in his highly cited 2017 paper, has been instrumental in enabling researchers to better understand complex genetic traits, disease associations, and population genetics by providing a clearer picture of how genetic variants are linked along chromosomes. While his citation count continues to grow, his work is recognized as a cornerstone in the push toward more accessible and precise genomic tools, directly impacting studies in personalized medicine and evolutionary biology. McElwain’s achievements underscore his role as a key innovator in making advanced genomic analysis practical for the broader scientific community.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Long Fragment Read (LFR) Technology: Cost-Effective, High-Quality Genome-Wide Molecular Haplotyping
13 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Complete Genomics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago